By Benjamin Chiou
Date: Monday 10 Jun 2024
(Sharecast News) - The share price of AIM-listed Arecor Therapeutics dropped by almost a third on Monday after the biopharma firm warned that its working capital requirements had "accelerated" while full-year revenues remain highly uncertain.
By Josh White
Date: Thursday 29 Feb 2024
(Sharecast News) - Arecor Therapeutics updated the market on an announcement made by its subsidiary Tetris Pharma on Thursday, regarding the launch of the 'Ogluo' glucagon prefilled autoinjector pen in the Netherlands.
By Josh White
Date: Wednesday 03 Jan 2024
(Sharecast News) - Arecor Therapeutics announced the appointment of Dr Helen Parris as senior vice president and commercial and general manager of its subsidiary Tetris Pharma on Wednesday.
Currency | UK Pounds |
Share Price | 76.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 199.00p |
52 Week Low | 66.00p |
Volume | 413 |
Shares Issued | 37.76m |
Market Cap | £28.88m |
Beta | 0.09 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:00 | 392 @ 73.50p |
11:00 | 392 @ 73.50p |
09:00 | 20 @ 73.50p |
09:00 | 20 @ 73.50p |
08:15 | 1 @ 78.00p |
CEO | Sarah Jennifer Howell |
CFO | David Ellam |
You are here: research